|
New data presented at ACC 2026 suggests that dulaglutide may be doing something far more dramatic than managing diabetes: it may be stabilising coronary plaques from the inside out.
|
 |
|
The collaboration will focus on advanced therapies, including weight loss.
|
|
|
The acquisition will add Belgium-based chromatography operations and a team of over 50 employees to Merck.
|
|
|
Whether the deal reaches its full value hinges on US regulatory milestones for Centessa’s lead candidate, cleminorexton.
|
|
|
This acquisition will add Syfovre and Empaveli to Biogen’s portfolio of medicines.
|
|
|
Pending IND clearance, Telomir aims to start a Phase I/II clinical trial with Telomir-1 as oral treatment.
|
|
